Hypophosphatemia leads to an increase in Na + -Pi co-transporter (NaPi-2) mRNA levels. This increase is post-transcriptional and correlates with a more stable transcript mediated by the terminal 698 nt of the NaPi-2mRNA. A 71 nt binding element was identified using renal proteins from rats fed control and low Pi diet. The binding of (-) Pi renal proteins to this transcript was increased compared to control proteins. The functionality of the cis element was demonstrated by an in vitro degradation assay. (-) Pi renal proteins stabilized transcripts that included the cis element compared to control renal extracts. The full-length NaPi-2 transcript, but not control transcripts, was stabilized by (-)Pi extracts. Insertion of the binding element into GFP as a reporter gene decreased chimeric GFP mRNA levels in transfection experiments. Our results suggest that the protein-binding region of the NaPi-2 mRNA functions as a cis acting instability element. In hypophosphatemia there is increased binding to the cis acting element and subsequent stabilization of NaPi-2 mRNA.
Introduction
Pi homeostasis is maintained by a well-defined membrane transport system (31). In mammals, renal Pi reabsorption is essential to Pi homeostasis. The renal tubule has an intrinsic ability to adjust the reabsorption rate of Pi according to need and availability of Pi (22) . The active reabsorption is mediated by the Na + -dependent Pi transporters (NaPi). NaPi type IIa transporters (NaPi-2) are expressed at the apical brush border membranes of the renal proximal tubules and are responsible for the regulated reabsorption of Pi in response to changes in dietary Pi (16;20) . NaPi type IIb transporters are homologous to NaPi type IIa but are found in a variety of other tissues such as intestine, lung, prostate and pancreas (4) . Disruption of the NaPi-2 gene in mice resulted in increased urinary Pi excretion, an 85% loss in brush-border membrane Na-Pi cotransport and significant hypophosphatemia (1) . Mice homozygous for NaPi-2 gene deletion did not respond to Pi depletion with an adaptive increase in Na-Pi cotransport and to parathyroid hormone (PTH) with a decrease in transport.
Therefore, Npt 2 is the major regulator of renal Pi homeostasis. There is a rapid adaptive increase in proximal tubule apical brush border membrane Na-Pi cotransport activity and Na-Pi-2 protein abundance that is mediated by microtubule-dependent translocation of presynthesized Na-Pi-2 cotransporter protein to the apical brush border membrane (13) . Dexamethasone inhibits Na-Pi cotransport and this is associated with a decrease in renal brush border membrane (BBM) Na-Pi-2 cotransporter abundance, and an increase in glucosylceramide content of the BBM (15) . Levi et al suggested that the increase in BBM glucosylceramide content played a role in mediating the effect of dexamethasone on Na-Pi cotransport activity (15) . Parathyroid hormone and a high Pi diet lead to a decrease in renal proximal tubular Na-Pi cotransport, that correlates with a decrease in the number of NaPi-2 transporters in the BBM due to their routing to the lysosome and subsequent degradation (6;7;23;24) . Several interacting proteins have been identified which may contribute either to its apical distribution or its subapical/lysosomal traffic (5;22).
However, chronic Pi depletion not only increases the transfer of preformed NaPi-2 to the apical BBM, but also increases the level of the NaPi-2 mRNA and protein level (9;30). The adaptive response to Pi depletion also occurs in vitro in opossum kidney cells where it has been shown to be a post-transcriptional effect (2;17;21) . In vivo in rats we have previously shown by nuclear transcript run-on experiments that the effect of chronic Pi depletion in rats is mainly post-transcriptional (9) although others have also found a transcriptional effect (8) . We studied the mechanisms involved in the post-transcriptional effect and found that this was dependent upon protein-RNA interactions (19) . Cytosolic renal proteins showed increased binding to the NaPi-2 mRNA 5'-UTR and this was associated with increased translation of NaPi-2 in vitro (19) . Renal proteins from rats fed a low Pi diet (-Pi) stabilized the NaPi-2 transcript in vitro and this was dependent upon the presence of the terminal 698 nt at the 3' end of the mRNA. In the present studies we have defined the region in the NaPi-2 mRNA 698 nt that mediates the binding of -Pi proteins. The functionality of the NaPi-2 mRNA protein-binding sequence was demonstrated in an in vitro degradation assay with renal proteins from control and low phosphate rats. In addition the protein binding region was inserted into a GFP reporter gene that was transfected into HEK 293 cells to study its effect on GFP expression. The sequence was shown to be an instability region in both systems. Therefore, the increase in binding of -Pi renal proteins to this region stabilizes the NaPi-2 mRNA.
Experimental procedures Experimental animals
Weanling male Sabra rats were fed a normal phosphate (0.3%), normal calcium (0.6%) or a low phosphate (0.02%) normal calcium (0.6%) diet (Teklad, IL) for 3 weeks. This low phosphate diet resulted in a serum phosphate of 4.1±0.5 mg/dl (control = 9.6±0.9 mg/dl) and serum calcium of 12.3±0.7 mg/dl (control = 10.6±0.5 mg/dl). After 3 weeks, the kidneys were removed under pentobarbital anesthesia and blood samples were taken for measurements of serum calcium and phosphate in a Roche autoanalyzer. Tissues for protein extracts were used immediately as described below.
Plasmids for RNA transcription
The full-length 2464 nt NaPi-2 transcript (accession number L13257) was prepared with T7 RNA polymerase from linearized plasmid construct containing the cDNA in pSPORT (a gift from J. Biber) as previously described. The 698 bp of the NaPi-2 cDNA, spanning the region of 1746-2464 of the NaPi-2 cDNA were subcloned into Bluescript II KS (Stratagene, La Jolla, CA) as described (19) . RNAs for the 698, 461, 362, 315, 231 and 144 nt were transcribed from this construct linearized with Not I, Msc I, Sty I, Sph I, Ava II, and Bbv II respectively using T3 RNA polymerase. The In vitro cell free degradation assay
In vitro degradation was performed essentially as described (18) . ( 
Results

Characterization of binding of renal cytosolic proteins to a defined region in the NaPi-2 mRNA
To study protein-RNA interaction we performed RNA electrophoretic mobility shift assays (REMSA) with renal proteins from control rats or rats fed a low Pi diet for 3 weeks and transcripts representing different regions of the NaPi-2 mRNA. A transcript that excluded the terminal 698 nt of the NaPi-2 mRNA did not bind ( (Fig 1A and B) and 231 nt (Fig 1 B and 2 ), did not affect binding. All these transcripts bound proteins resulting in a shift of the free probe, which was dose dependent. The larger shifted complexes when more protein is added may represent the binding of additional subunits of the protein RNA complex. Further shortening of the transcript to 144 nt resulted in no binding (Fig 1A and B) . This suggests that the binding region is between 144 to 231 nt (Fig. 1B) . Therefore, we transcribed RNA that deleted the 164 nt between the 151 and 315 nt transcripts (Fig 1B, ∆461 nt) . This ∆461 nt transcript did not bind renal proteins (Fig 1A nd B) . These results indicate that the binding region is between 151 and 231 nt in the 698 nt represented in Fig 1B. Transcripts of 95 (not shown) and 71 nt in this region (Fig. 1A) were sufficient for protein binding ( Fig. 1 A and B) , defining the minimal protein binding region that corresponds to 1889-1960 of the NaPi-2 cDNA at the junction of the coding region and the 3'-UTR. Renal proteins from control rats showed significantly reduced binding to the 71 (not shown), 95 nt and to the 231 nt transcripts (Fig. 1C) . The decreased binding may have been in part due to some degradation of the transcript by the renal proteins from control rats. This is evident by the partially degraded excess free probe that remains after binding with control renal proteins but not with (-)Pi proteins. With (-)Pi proteins the increased binding utilizes all the probe (Fig. 1C) .
To show specificity of the binding we performed competition experiments.
The binding of -Pi proteins to the 231 nt transcript was effectively competed for by excess unlabeled 231 nt transcripts already at x20 competitor excess (Fig 2) . The 144 nt transcript, which did not bind renal proteins (Fig 1A) , was also much less effective as a competitor for the binding to the 231 nt transcript (Fig 2) . In addition, in Fig 2 it is shown that a 71 nt transcript is sufficient to compete for binding of -Pi renal proteins to the 698 nt NaPi-2 trancript. The competition experiments demonstrate the specificity of protein binding to the NaPi-2 element. There is increased binding of (-)Pi renal proteins to the NaPi-2 transcript compared to proteins of normal rats. This binding is to a 71 nt region spanning the junction of the coding region and the 3'-UTR of the NaPi-2 mRNA.
Renal cytosolic proteins from -Pi stabilize the NaPi-2 transcript in an in vitro degradation assay at the protein binding region
We have previously shown that the increase in renal NaPi-2 mRNA levels in hypophosphatemic rats can be reproduced in vitro by an in vitro degradation assay (19) . In this assay labeled transcripts for the NaPi-2 mRNA are incubated with cytosolic renal proteins from control or -Pi rats. The amounts of transcripts remaining with time are determined, and this has been shown to represents the degradatory processes that occur in vivo. We showed that the full-length 2464 nt NaPi-2 transcript and the terminal 698 nt were stabilized by -Pi proteins, correlating with mRNA levels in vivo. However, a transcript of the 5' 1043 nt that does not include the 698 nt binding region was not stabilized in this assay (19) . We have now performed the in vitro degradation assay with the shorter transcripts that we have now shown are relevant for binding. We analyzed the transcripts of 461, 231 and 95 nt (Fig. 1B) that showed increased binding to the -Pi renal proteins compared to control proteins.
These three transcripts were stabilized in five different in vitro degradation assay experiments ( Fig 3A) . The t 1/2 for the degradation of the 95 nt transcript was ~2 h with renal proteins from control rats and ~5 h with proteins from -Pi rats. The t 1/2 for both the 231 and the 461 nt transcripts was <0.5 h with control proteins and >2 h with -Pi proteins. Despite the differences in degradation time between the shorter transcript of 95 nt (2 h) and the longer transcripts (0.5 h) in this assay, all the transcripts were stabilized by the -Pi proteins compared to proteins from control rats.
In contrast, a non-relevant transcript for the transferrin receptor showed the same degradation rate with both control and -Pi renal proteins (Fig 3B) similar to the 5' 1043 nt NaPi-2 transcript. These results indicate that the protein binding region of the NaPi-2 mRNA is also the target region that determines NaPi-2 mRNA stability in response to a -Pi diet. We also studied renal proteins from rats fed a low calcium diet for 10 days, where serum phosphate is increased, serum calcium decreased and PTH levels markedly increased with no change in NaPi-2 mRNA levels (9). The in vitro degradation time course of the 461 nt NaPi-2 transcript with proteins from control and low calcium rat kidneys was the same (Fig 3, bottom panel) . This result demonstrates that the in vitro studies accurately reflect the in vivo changes in NaPi-2 mRNA and underlines the stabilizing effect of (-)Pi renal proteins in this assay.
The protein-binding region decreases levels of a reporter gene mRNA and protein in transfected cells
The correlation between binding and stabilization of the NaPi-2 transcript by -Pi renal proteins suggests that the protein binding protects the NaPi-2 transcript in hypophosphatemia resulting in increased NaPi-2 mRNA and protein levels in vivo. To study the instability effect of the protein-binding region, we inserted different cDNAs of the NaPi-2 transcript at the 3' end of the GFP cDNA in an expression vector driven by a CMV promoter. The wild type and chimeric constructs were transiently transfected into HEK293 cells. These cells have the same protein binding pattern to the NaPi-2 transcript as do protein from rat kidney tissue (not shown). At 24 hours GFP mRNA levels analyzed by Northern blots and GFP protein levels by immunofluorescence. Chimeric transcripts containing 461, 362 and 95 nt decreased GFP mRNA and protein levels (Fig 4) , with the effects of 461 > 95 > 362 nt. These transcripts all contained the NaPi-2 mRNA protein-binding region (Fig. 1) . Figure 4B shows a representative gel for GFP mRNA levels performed in triplicate for each chimeric construct. Quantification of 4 separate experiments showed that the GFP mRNA levels were decreased with the NaPi-2 461, 95 and 362 nt inserts by 70-90%.
Insertion of the 144 nt that did not bind the -Pi renal proteins did not affect GFP mRNA. Correction after co-transfection with a β−gal expression plasmid confirmed that the results were not due to differences in transfection efficiency (not shown). The chimeric GFP cDNAs all used the same CMV promoter suggesting that the differences in expression are not a transcriptional effect. Furthermore, when actinomycin D was added to cells transfected with the GFP plasmids containing such insertions, there was no difference in GFP mRNA decay (not shown). Therefore the effect of the protein-binding element of the NaPi-2 mRNA to decrease GFP levels is post-transcriptional at the level of mRNA stability. The amount of GFP protein in the transfected cells correlated with GFP mRNA levels (Fig 4C) . |However, the amount of GFP protein expression as shown by immunofluorescence provides a qualitative rather than a quantitative representation of the amount of GFP protein. The measurement of GFP mRNA in the Northern blot is the direct indication of the effect of the NaPi-2 inserts on transcript levels and stability.
The transfection experiments together with the in vitro degradation and binding experiments suggest that the junctional region between the 3' end of the coding region and the 5' end of the 3'-UTR is important for binding and regulation of RNA stability.
Discussion
Renal phosphate homeostasis involves the coordinate regulation of Pi reabsorption by both intrinsic renal sensing as well as the response to hormonal signals such as parathyroid hormone (14) . The regulated Pi reabsorption is through the Na-Pi-2 cotransporter whose gene is Npt2. The regulation of the NaPi-2-mediated Na-Pi cotransport by dietary Pi occurs primarily at the post-transcriptional level (21;26), despite the identification of several cis-acting elements in the promoter region (8;27;28) . We have previously shown that -Pi cytoplasmic renal proteins stabilized the NaPi-2 transcript in an in vitro degradation assay, which was dependent upon an intact NaPi-2 3'-end (19) . We also showed that there was increased translation of NaPi-2 in vitro in reticulocyte lysate assays and in vivo in pulse chase experiments with 35 S-methionine injected rats. This increased translation correlated with increased binding of -Pi renal proteins to the 5'-UTR by UV cross-linking gels. Therefore, (-)Pi diet regulates NaPi-2 gene expression by affecting protein-RNA interactions. In addition, Levi et al showed that at short time intervals (2 h) when rats where transferred from a high to a (-)Pi diet there was an increase in NaPi-2 protein with no change in mRNA levels, indicating an effect at the level of translation or protein stability (14) . In the chronic (-)Pi model there is an increase in mRNA levels that our results suggest is post-transcriptional (19) . We have now defined the region in the NaPi-2 mRNA at the junction of the coding region and the 3'-UTR that binds -Pi renal proteins by REMSA. UV cross-linking gels do not detect the binding to this region (19) . REMSA is a more sensitive assay for RNA-protein binding and more closely represents the interactions in vivo, because it utilizes non-denaturing conditions. The binding of renal proteins to the defined NaPi-2 region was increased by -Pi renal proteins. A transcript for this region was stabilized by -Pi renal proteins in an in vitro degradation assay, similar to the full-length NaPi-2 transcript. The stabilizing effect of -Pi renal proteins correlates with NaPi-2 mRNA levels in vivo.
Therefore, this defined region in the NaPi-2 transcript is an instability cis-acting element. Under normal conditions there is limited binding of cytosolic proteins to this cis-acting element and this determines the steady state levels of NaPi-2 mRNA and NaPi-2 protein. In hypophosphatemia there is increased binding to this element, which protects the RNA from degradation resulting in an increase in NaPi-2 mRNA levels.
To demonstrate the destabilizing properties of the defined cis-acting element, we inserted the cDNA coding for the element into the 3'-end of a GFP reporter gene and studied its effect upon GFP mRNA and protein levels by transient transfections in were incubated with cytosolic proteins from rats fed control or -Pi diets. At different time periods RNA was extracted and analyzed by gel electrophoresis. The 461 nt NaPi-2 transcript and the TFr transcript were incubated with protein extract and analyzed together (C). The NaPi-2 transcripts and not the control TFr transcript were stabilized by -Pi renal proteins. The 461 nt transcript was also studied with renal cytosolic proteins from control rats and rats fed a low calcium diet (D) where NaPi-2 mRNA levels are unchanged (9) . There was no change in the in vitro degradation rates. 362 nt decreased GFP mRNA and protein levels, but not the transcript of 144 nt that also did not bind renal proteins (Fig. 1) .
